Cilomni-10 vs Cilomni-T 10/40: How Doctors Choose
Cilomni-10: Cilnidipine Tablets IP 10 mg
Cilomni-10 carries one molecule, Cilomni-T 10/40 carries two. This article explains the difference, what doctors consider when choosing, and why patients should never switch by themselves.
What Cilomni-10 and Cilomni-T 10/40 Contain
Cilomni-10 is a film-coated tablet containing Cilnidipine IP 10 mg, supplied as 10 x 10 tablets. It is a single-molecule calcium channel blocker.
Cilomni-T 10/40 is a Cilnidipine and Telmisartan tablet containing cilnidipine 10 mg plus telmisartan 40 mg. It is a fixed-dose combination of two different classes.
Both are marketed by EMK Omni Pharma and both are prescription-only Schedule H medicines. The cilnidipine part is identical in strength, so the real question is whether a second molecule belongs in the same tablet for a particular patient. That is decided by the doctor from readings, examination and tests, not by comparing labels.
Why a Cilnidipine and Telmisartan Combination Exists
Blood pressure is regulated by several systems at once. Cilnidipine works directly on the muscle of the artery wall, letting vessels relax. Telmisartan is an angiotensin receptor blocker and works through a hormonal pathway that also controls vessel tone and salt and water handling.
Attacking two pathways at once often achieves more than pushing one to its limit, and frequently with fewer effects than a very high dose of a single medicine would produce. There is a second, practical advantage: ARBs are known to reduce the fluid collection around the ankles that calcium channel blockers can cause, so the two partners complement each other.
Finally, one tablet is easier to remember than two. Adherence over years is one of the strongest determinants of how well hypertension is controlled.
What a Doctor Weighs When Choosing Between Them
Several things feed into the decision:
- How far readings are from target. A small gap may be closed with one molecule; a wide gap often needs two.
- What you are already taking. If you are on a separate ARB, a combination could duplicate it.
- Kidney function and potassium levels. ARBs need attention here, and blood tests may be repeated after starting.
- Pregnancy status and plans. Telmisartan is not used in pregnancy, which alone can settle the choice.
- Side effects so far. Ankle swelling on a calcium channel blocker may push a doctor towards adding an ARB.
- Number of tablets you are managing. For someone on several medicines, reducing the count genuinely helps.
- The need to fine-tune. A fixed-dose combination cannot be adjusted one molecule at a time, so doctors sometimes keep the components separate on purpose.
Why You Must Not Switch Between Them on Your Own
The two products look similar on a shelf and the names differ by a few characters, which makes self-switching tempting and risky.
Moving from Cilomni-10 to the combination adds a whole new class of medicine without the checks that normally go with it, including kidney function and potassium testing and a review of pregnancy status. Moving the other way removes a molecule your doctor deliberately added, and pressure may rise quietly over weeks without you noticing anything.
There is also a dispensing point. Your prescription names one specific product. A licensed chemist should dispense what is written and not substitute on request. If you believe a change is warranted, take that to the prescriber.
The same applies to strength. Never assume that taking two tablets of a lower strength equals one of a higher strength.
Questions to Ask at Your Next Consultation
A few direct questions make the choice clearer for you:
- What is my target blood pressure, and how far am I from it right now?
- Am I on one molecule or two, and why was that chosen for me?
- If we add a second molecule, will it be a separate tablet or a combination, and why?
- Which tests will you repeat after any change, and when?
- What should I watch for at home in the first two weeks after a change?
- Is anything in my prescription unsuitable if I plan a pregnancy?
Carry your home readings and your current strips to the appointment. Seeing the actual packs removes any confusion between products with similar names.
This article is for general information only and is not a substitute for advice from a registered medical practitioner.
Frequently asked questions
- Is Cilomni-T 10/40 stronger than Cilomni-10?
- It is not a stronger dose of cilnidipine, which stays at 10 mg. It adds telmisartan 40 mg, a different class working through another pathway.
- Can I take two Cilomni-10 tablets instead of a combination?
- No. More of the same molecule is not the same as adding a second mechanism, and doubling a dose without advice is unsafe.
- Why did my doctor move me to the combination?
- Common reasons are readings still above target, a wish to reduce the number of tablets, or ankle swelling on a calcium channel blocker alone.
- Can the chemist give me the combination if the single is out of stock?
- No. A pharmacist should dispense what the prescription states. Ask the prescriber for guidance if a product is unavailable.
- Does the combination need more blood tests?
- Adding an ARB usually means checking kidney function and potassium after starting, and periodically thereafter, as your doctor directs.
- Which one is right if I am planning a pregnancy?
- Tell your doctor before conceiving. Telmisartan is not used in pregnancy, so the whole plan will be reviewed.
Need Cilomni-10 for your pharmacy, hospital or clinic?
EMK Omni Pharma supplies through authorised channels across Karnataka. Send an enquiry and our team will respond during business hours.
Related guides
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.